A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive write of pancreas cancer. Scientists at the Kimmel Cancer bear on at Jefferson in Philadelphia have discovered that the protein pp32 - which normally applies the brakes on a cancer-causing gene - is missing in an aggressive form of pancreas cancer. Though the bring home the bacon is preliminary the researchers say the disappear protein could eventually change state a marker for the disease and a potential drug aim. Researchers led by Jonathan Brody. Ph. D. assistant professor of Surgery. Charles Yeo. M. D.. Samuel D. bring in Professor and chair of Surgery and Agnieszka Witkiewicz. M. D. assistant professor of Pathology. Anatomy and Cell Biology all of Jefferson Medical College of Thomas Jefferson University undergo shown in experimental models that without the protein mutations in the cancer-causing gene K-ras can take over turning cells malignant. Adding pp32 to pancreas cancer cells that have K-ras mutations and lack the protein can slow the growth of these fast-growing cells leading the researchers to speculate that losing pp32 might be a critical event in determining how aggressively a pancreas cancer behaves. They report their initial findings online in the journal Modern Pathology. As per Dr. Brody prior laboratory and animal studies undergo shown that pp32 inhibits K-ras-activating gene mutations open in more than 90 percent of all pancreas cancers and in some early pre-malignant lesions as come up. But in a subset of fast-moving. "poorly differentiated" pancreas cancers the scientists observed that "pp32 is either reduced or lost," Dr. Brody says. "Losing the protein in pre-malignant lesions could be a marker for an aggressive form of pancreas cancer."It's rare to find laboratory studies that parallel what we see in actual pancreatic tumors," Dr. Brody says. "Connecting a protein that can inhibit a critical mutation open in almost every pancreas cancer to the pathology is powerful information. These types of studies can help us understand more about the early development of pancreas cancer on a molecular level."If we are able to learn more about this molecule this may be a potential aim that we could turn on in aggressive types of pancreas cancers," he notes. "In theory if we could sight a way to upregulate this molecule in these pancreas cancers we may be able to arrest these fast-growing cancer cells as we did in experiments in this study. As we understand its molecular interactions we could also somehow sight the things that regulate it and extend our molecular understanding of this devastating disease."Posted by: Andria
Forex Groups - Tips on Trading
Related article:
http://www.thecancerblog.org/blogs/permalinks/10-2007/proteins-role-in-deadly-form-of-pancreatic-cancer.html
comments | Add comment | Report as Spam
|
